Comments
Ipca Laboratories Ltd on Tuesday reported a net profit of Rs 76.61 crore for the fourth quarter ended March 31, 2012 as against a net profit of Rs 58.57 crore for the same period of previous year.
The net sales stood at Rs 553.11 crore in the quarter under review compared with Rs 473.78 crore in the corresponding period of last fiscal.
The financial figures of the current quarter and fiscal are not comparable with those of the previous financial year due to amalgamation of Tonira Pharma with the company with effect from April 1, 2011, it said.
For the year ended Mach 31, 2012, the company reported a net profit of Rs 280.17 crore against Rs 255.37 crore during the previous fiscal.
The company recommended a final dividend of Rs 1.20 per share of Rs 2 each (60 per cent) for the financial year 2011-12.
Shares of Ipca Laboratories ended at Rs 321.35 on the BSE, down 4.06 per cent from its previous close.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.